Skip to main
CTSH
CTSH logo

CTSH Stock Forecast & Price Target

CTSH Analyst Ratings

Based on 38 analyst ratings
Hold
Strong Buy 13%
Buy 26%
Hold 53%
Sell 3%
Strong Sell 5%

Bulls say

Cognizant Tech Solutions has demonstrated robust revenue growth, with Health Sciences revenue increasing by 10.4% year-over-year in constant currency, and overall revenue growth of 6.8% year-over-year on a reported basis. The company's bookings increased by 11% year-over-year, reaching a total of $27.1 billion, underscoring strong demand and successful contract acquisitions with the signing of 10 large deals in the latest quarter. Additionally, management guidance indicates anticipated operating margin expansion of 20 to 40 basis points, supported by advancements in AI and automation, which are likely to enhance profitability in future periods.

Bears say

Cognizant Tech Solutions faces a negative outlook primarily due to a marginal decline in blended utilization amidst the integration of its recent Belcan acquisition, indicating operational challenges. Furthermore, the company anticipates a deceleration in revenue growth driven by decreased global technology spending and continued subdued demand for discretionary IT services, which is compounded by macroeconomic headwinds. Lastly, despite solid quarterly results and effective management strategies, the initial organic growth forecast for fiscal year 2025 is below that of its large-cap IT services peers, raising concerns about its ability to accelerate revenue growth while maintaining a sustainable margin profile.

CTSH has been analyzed by 38 analysts, with a consensus rating of Hold. 13% of analysts recommend a Strong Buy, 26% recommend Buy, 53% suggest Holding, 3% advise Selling, and 5% predict a Strong Sell.

This aggregate rating is based on analysts' research of Cognizant Technology Solutions and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Cognizant Technology Solutions (CTSH) Forecast

Analysts have given CTSH a Hold based on their latest research and market trends.

According to 38 analysts, CTSH has a Hold consensus rating as of Jul 1, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $77.42, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $77.42, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Cognizant Technology Solutions (CTSH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.